BiopharmIQ by Amp ✓

@BiopharmIQ · PDUFA 🗓️ → · joined 20 Dec 2016

Catalyst Calendar, Big Mover stocks & model portfolios. Database & tools to help with your biotech investing & BD. not invstmnt advice. https://t.co/5njnanqtbK #biotech

29 927Followers

396Following

16 841Posts total

28.3KViews on collected posts

Neueste Beiträge

BiopharmIQ by Amp ✓@BiopharmIQ23 Sep

Ready for Q4 2026 catalysts?! 👀 We’re tracking 88 Ph2 & Ph3 readout catalysts for Q4 2026 Before you reposition your portfolio, check what’s due. Build your watchlist before the headlines. 9/23 snapshot. Counts/timing may change. https://t.co/d2VlDXhmGW

2.6K views · 2 likes · 0 reposts · 1 replies Open on X →

BiopharmIQ by Amp ✓@BiopharmIQ23 Sep

📣 Join our Biotech Daily Stock Moves community... 📌 hottest headlines 🔥 📌 stock moves 📈📉 Stay informed and make smarter investing! Visit the link to join our community.👇 https://t.co/J93b6E1Q58 666 views · 1 likes · 0 reposts · 0 replies Open on X →

BiopharmIQ by Amp ✓@BiopharmIQ23 Sep

$ACIU +3% at open on positive Ph2 data for ACI-7104 in early Parkinson’s disease 📈 VacSYn Part 1: • Met all primary safety, tolerability & immunogenicity endpoints • 100% of treated patients developed antibodies after 3 immunizations What’s next? See the graphic and https://t.

2.2K views · 2 likes · 0 reposts · 1 replies Open on X →

BiopharmIQ by Amp ✓@BiopharmIQ23 Sep

Biotech Stock News 9/23 @ Open 2.4K views · 1 likes · 0 reposts · 0 replies Open on X →

BiopharmIQ by Amp ✓@BiopharmIQ23 Sep

$ANVS +3% at open after partnering with Weave Bio to support NDA preparation for buntanetap in Alzheimer’s. Which Alzheimer’s readouts are coming next? Build your watchlist before the headlines hit 👇 https://t.co/zonmh7ZvXj 360 views · 0 likes · 0 reposts · 0 replies Open on X →

BiopharmIQ by Amp ✓@BiopharmIQ23 Sep

Biotech Stock News 9/23 @ Open $SPRC 4% Enhancement of U.S. Patent Portfolio $ANVS 3% NDA preparation for Buntanetap $ACIU 3% ACI-7104 Safety & Immunogenicity Data $PHIO 1% Clinical Development Update & Catalysts $BCDA 1% Update on FDA and PMDA submissions $KAPA 1% Presenting at

5K views · 10 likes · 0 reposts · 2 replies Open on X →

BiopharmIQ by Amp ✓@BiopharmIQ3 Sep

$IONS FDA approves first treatment for Alexander disease, a rare brain disorder 🧠 Zanvastro (zilganersen) approved for pediatric and adult patients, from infancy through adulthood. • antisense oligonucleotide, reduces GFAP production • administered by spinal injection once http

4.6K views · 11 likes · 5 reposts · 1 replies Open on X →

BiopharmIQ by Amp ✓@BiopharmIQ3 Sep

BiopharmIQ by Amp ✓@BiopharmIQ28 Aug

IONS: 2 readouts today $IONS is down 2.75% to $60.71 today (-$1.72 vs. prior close of $62.43), according to BPIQ market data. • Eplontersen, Phase 3 CARDIO-TTRansform: The detailed ATTR-CM dataset confirmed the trial missed its overall primary endpoint. A nominally positive 6.4K views · 10 likes · 1 reposts · 3 replies Open on X →

Im Vergleich zu Konten gleicher Größe

9 Beiträge aus den letzten 90 Tagen, verglichen mit der Größenklasse 10K–100K Follower. wird weit gezeigt, aber nur wenige dieser Zuschauer reagieren.

Medianaufrufe2 571dieses Konto924Median für 10K–100K

Reichweite, %8.59%dieses Konto3.62%Median für 10K–100K

Interaktion, %0.15%dieses Konto1.52%Median für 10K–100K

Kennzahl	Dieses Konto	Median für 10K–100K	Verhältnis
Medianaufrufe pro Beitrag	2 571	924	2.78×
Reichweite (Aufrufe ÷ Follower)	8.59%	3.62%	2.37×
Interaktionsrate	0.15%	1.52%	0.10×

Weitere Konten dieser Größe → Mit einem anderen Konto vergleichen → Wie diese Vergleichswerte entstehen →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

6.4K28 Aug

4.1K3 Sep

4.6K

5K23 Sep

360

2.4K

2.2K

666

2.6K

Last 9 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.22%28 Aug

0.34%3 Sep

0.41%

0.26%23 Sep

0.00%

0.04%

0.14%

0.15%

0.12%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes64.4%47 in total

Reposts13.7%10 in total

Replies11.0%8 in total

Quotes4.1%3 in total

Bookmarks6.8%5 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Neueste Beiträge

Im Vergleich zu Konten gleicher Größe

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Ähnliche Konten